Healthcare provider profile · identity verified

Wardah Siddiq, MD

Family Practice · ROCHESTER, NY · NPI 1437611886

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	592	176
Amlodipine Besylate	Amlodipine Besylate	442	142
Losartan Potassium	Losartan Potassium	266	82
Gabapentin	Gabapentin	249	67
Lisinopril	Lisinopril	215	63
Metformin Hcl	Metformin Hcl	164	49
Omeprazole	Omeprazole	163	47
Rosuvastatin Calcium	Rosuvastatin Calcium	152	54
Metoprolol Succinate	Metoprolol Succinate	146	38
Hydrochlorothiazide	Hydrochlorothiazide	144	52
Albuterol Sulfate Hfa	Albuterol Sulfate	138	57
Carvedilol	Carvedilol	133	30
Famotidine	Famotidine	127	45
Metformin Hcl Er	Metformin Hcl	114	32
Levothyroxine Sodium	Levothyroxine Sodium	110	32
Duloxetine Hcl	Duloxetine Hcl	94	27
Fluticasone Propionate	Fluticasone Propionate	93	40
Chlorthalidone	Chlorthalidone	90	36
Meloxicam	Meloxicam	90	34
Jardiance	Empagliflozin	88	35
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	86	34
Trazodone Hcl	Trazodone Hcl	83	21
Pantoprazole Sodium	Pantoprazole Sodium	80	32
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	71	22
Tamsulosin Hcl	Tamsulosin Hcl	71	16
Metoprolol Tartrate	Metoprolol Tartrate	70	18
Allopurinol	Allopurinol	69	21
Hydralazine Hcl	Hydralazine Hcl	69	13
Ibuprofen	Ibuprofen	62	25
Escitalopram Oxalate	Escitalopram Oxalate	58	11
Hydroxyzine Hcl	Hydroxyzine Hcl	58	16
Pravastatin Sodium	Pravastatin Sodium	58	15
Triamcinolone Acetonide	Triamcinolone Acetonide	56	27
Montelukast Sodium	Montelukast Sodium	54	20
Spironolactone	Spironolactone	54	21
Clopidogrel	Clopidogrel Bisulfate	51	12
Naproxen	Naproxen	48	18
Simvastatin	Simvastatin	48	11
Amitriptyline Hcl	Amitriptyline Hcl	46	17
Furosemide	Furosemide	45	19
Glipizide	Glipizide	44	15
Diclofenac Sodium	Diclofenac Sodium	38	16
Finasteride	Finasteride	38	11
Quetiapine Fumarate	Quetiapine Fumarate	38	suppressed
Rybelsus	Semaglutide	38	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	37	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	14
Eliquis	Apixaban	35	16
Glipizide Er	Glipizide	35	suppressed
Levetiracetam	Levetiracetam	35	suppressed
Sertraline Hcl	Sertraline Hcl	35	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	34	suppressed
Pregabalin	Pregabalin	34	suppressed
Bupropion Xl	Bupropion Hcl	31	13
Hydrocortisone	Hydrocortisone	31	12
Symbicort	Budesonide/Formoterol Fumarate	31	suppressed
Januvia	Sitagliptin Phosphate	30	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Tramadol Hcl	Tramadol Hcl	30	suppressed
Ozempic	Semaglutide	29	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	suppressed
Alendronate Sodium	Alendronate Sodium	27	11
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	25	suppressed
Topiramate	Topiramate	25	suppressed
Labetalol Hcl	Labetalol Hcl	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	24	suppressed
Warfarin Sodium	Warfarin Sodium	24	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Glimepiride	Glimepiride	23	suppressed
Atenolol	Atenolol	22	11
Prednisone	Prednisone	22	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Lidocaine	Lidocaine	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Irbesartan	Irbesartan	20	suppressed
Vascepa	Icosapent Ethyl	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Torsemide	Torsemide	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	16	suppressed
Doxepin Hcl	Doxepin Hcl	16	suppressed
Fluconazole	Fluconazole	16	12
Lovastatin	Lovastatin	16	suppressed
Potassium Chloride	Potassium Chloride	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Valsartan	Valsartan	16	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	14
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	14	14
Ciclopirox	Ciclopirox Olamine	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	11
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Zonisamide	Zonisamide	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	12	suppressed
Felodipine Er	Felodipine	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Mycophenolate Mofetil	Mycophenolate Mofetil	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	11
Bupropion Hcl	Bupropion Hcl	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Lactulose	Lactulose	11	suppressed
Nucynta	Tapentadol Hcl	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error